15 16 These authors contributed equally to this work. 17 18 High mobility group box 1 in dilated cardiomyopathy. Kido et al. 2 2 19 20 Abstract 21 Objectives: We hypothesized that systemic administration of high-mobility group box 1 22 fragment attenuates the progression of myocardial fibrosis and cardiac dysfunction in a hamster 23 model of dilated cardiomyopathy by recruiting bone marrow mesenchymal stem cells thus 24 causing enhancement of a self-regeneration system.
168 Corporation, Carlsbad, Calif) and using hamster-specific primers for tumor necrosis factor-α 169 stimulating gene 6 (TSG-6), vascular endothelial growth factor (VEGF), and CXCR4. Each 170 sample was analyzed in duplicate for each gene studied. Data were normalized to 171 glyceraldehyde-3-phosphate dehydrogenase expression level. For relative expression analysis, 172 the ddCT method was used, and a sample from a control hamster was used as reference. The 173 real-time polymerase reaction was also conducted using Fast SYBR Green Master Mix and 174 primers designed for hepatic growth factor and glyceraldehyde-3-phosphate dehydrogenase as 175 shown in Table 1 . For relative expression analysis, we prepared a 5-fold serial standard curve 176 using a sample from a HMGB1 hamster as reference. 185 Twenty-week-old J2N-k hamsters were treated with HMGB1 (HMGB1, n= 11) or PBS (control, 186 n= 9) as described above. An additional treatment group received monthly administration of 187 HMGB1 fragment 3 times, (monthly HMGB1, n= 9) to evaluate the long-term therapeutic 188 effects of HMGB1 fragment (Fig 1) . The animals were randomly allocated to each treatment 189 group and housed after the initial treatment. 332 Survival of J2N-k hamsters was assessed using the Kaplan-Meier method. There was no 333 significant difference in survival between HMGB1 and control. In contrast, the monthly 334 HMGB1 group all survived to the full 42 weeks, and they showed significantly improved 335 survival rate compared with control group (log-rank p=0.001) (Fig 9) . 338 Survival after each treatment assessed by the Kaplan-Meier method.
